Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07620535 · ClinicalTrials.gov registry record
Decision Counseling and Follow-up for Shield+ Patients
A clinical trial, sponsored by Guardant Health.
- Not yet
- Registry status
- 350
- Enrollment target
NCT07620535 is a clinical trial that has not yet begun recruiting, run by Guardant Health. The registered enrollment target is 350 participants.
The verdict
NCT07620535 has not yet begun recruiting, sponsored by Guardant Health.
- NOT YET RECRUITING
- Registry status
- 350 participants
- Enrollment target
Study Summary
Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.
Interventions
- BEHAVIORAL Decision Counseling Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07620535
The ClinicalTrials.gov registry entry for NCT07620535 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Guardant Health, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decision Counseling Session is the first listed.
NCT07620535 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07620535 about?
NCT07620535 is a clinical study titled "Decision Counseling and Follow-up for Shield+ Patients". Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.
What is the current status of trial NCT07620535?
This trial is currently not yet recruiting. The enrollment target is 350 participants. The study started on 2026-06. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07620535?
The interventions under investigation include: Decision Counseling Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT07620535?
This trial is sponsored by Guardant Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.